NEO (NeoGenomics, Inc.) Stock Analysis - Analyst Ratings

NeoGenomics, Inc. (NEO) is a publicly traded Healthcare sector company. As of May 21, 2026, NEO trades at $8.90 with a market cap of $1.09B and a P/E ratio of 0.00. NEO moved +6.08% today. Year to date, NEO is -26.32%; over the trailing twelve months it is +11.39%. Its 52-week range spans $4.72 to $19.12. Analyst consensus is buy with an average price target of $14.94. Rallies surfaces NEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate NEO?

11 analysts cover NEO: 0 strong buy, 8 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.94.

NEO Key Metrics

Key financial metrics for NEO
MetricValue
Price$8.90
Market Cap$1.09B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$19.12
52-Week Low$4.72
Volume975
Avg Volume0
Revenue (TTM)$727.33M
Net Income$-108.03M
Gross Margin43.21%

NEO Analyst Consensus

11 analysts cover NEO: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.94.

Latest NEO News

Recent NEO Insider Trades

  • Stone Warren sold 22.13K (~$276.68K) on Jan 20, 2026.
  • Olivo Alicia C sold 20.92K (~$250.99K) on Nov 25, 2025.
  • Olivo Alicia C sold 4.92K (~$49.18K) on Oct 16, 2025.

Common questions about NEO

What do analysts rate NEO?
11 analysts cover NEO: 0 strong buy, 8 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.94.
Does Rallies show NEO price targets?
Yes. Rallies tracks NEO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is NEO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NEO. It does not provide personalized investment advice.
NEO

NEO